Maruho
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 4/20/2022
Pipeline by Phase
Therapeutic Focus
Clinical Trials (25)
Phase III Study of ASP2151 in Herpes Simplex Patients
Started: 8/1/2013
Open-label Study of ASP2151 in Herpes Simplex Patients
Started: 11/1/2013
A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Started: 10/30/2017
A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts
Started: 1/1/2017
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
Started: 12/1/2015
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
Started: 10/1/2015
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
Started: 10/1/2015
Phase III Study of ASP2151 in Herpes Zoster Patients
Started: 8/1/2013
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
Started: 4/20/2022
A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis
Started: 6/1/2019
ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
Started: 10/5/2017
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
Started: 3/8/2017
Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
Started: 11/1/2015
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
Started: 7/1/2016
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Started: 10/1/2015
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Started: 1/1/2015
Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
Started: 5/1/2015
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Started: 2/1/2011
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
Started: 4/1/2014
Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis
Started: 8/1/2008
Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients
Started: 7/1/2009
Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers
Started: 2/6/2017
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
Started: 3/1/2014
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
Started: 1/1/2014